Patrick Jiang

Patrick Jiang has a diverse work experience spanning various roles and companies. Patrick is currently a Co-founder and Chief Business Officer at InGel Therapeutics, Inc., a role they started in January 2022. Prior to that, they were a member of the Strategy Team at Nucleate starting in October 2021. Patrick also gained experience as a Business Development Intern at Genentech from May 2022 to August 2022. Patrick worked at Horizon from March 2014 to May 2022, where they held various commercial and business development positions. Additionally, Patrick founded and served as the CEO of Phocus Technologies from 2016 until June 2020. Patrick began their career as a Consulting Associate at Marakon from August 2012 to May 2014.

Patrick Jiang has a Bachelor's degree in Math from Northwestern University, which they obtained from 2008 to 2012. Later, in 2016 to 2017, they attended General Assembly for a part-time class in Data Science. Currently, they are pursuing a Master of Business Administration (MBA) degree at Harvard Business School, expected to be completed in 2023.